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Background:  Whether  or not,  obesity  negatively  inﬂuencing  the  outcomes  of  primary  total  hip  arthro-
plasty  (THA)  remains  a  controversial  issue.  Though  observational  studies  focused  on  this  topic,  the
reported  conclusions  remain  inconsistent.  Therefore,  we  performed  a meta-analysis  of prospective  cohort
studies to evaluate  if obesity  negatively  affects:  (1)  the  overall  complication  rate  (incidence  of  dislocation,
deep  infection  and  osteolysis);  (2) functional  outcome;  (3)  operative  time  and  stay  duration  in  hospital
for the  primary  THA.
Methods:  We searched  the  PubMed,  Embase,  Web  of  Science,  and  the Cochrane  Library  until  July  2014 to
identify  the  eligible  prospective  studies.  The  Newcastle  Ottawa  Scale  (NOS)  was  used for  quality  assess-
ment  of  the  included  studies.  We  extracted  and pooled  the data.  As  for continuous  data,  mean  difference
(MD)  was  calculated;  for  dichotomous  variables,  we  calculated  a weighted  relative  risk  (RR)  with its  95%
conﬁdence  interval.  Heterogeneity  was  evaluated  using  I2 statistics.  P ≤ 0.05 was  thought  to  be signiﬁcant.
Results:  Fifteen  studies  were  eligible  for data  extraction,  which  involved  11,271 total  hip  arthroplasties.
The  pooled  data  of  complication  rate  demonstrated  that  obese  patients  suffered  higher rates  of compli-
cation  (RR:  1.68,  95% CI  1.23  to 2.30,  P = 0.0004),  dislocation  (RR:  2.08, 95% CI  1.54  to  2.81,  P <  0.0001)  and
deep  infection  (RR:  2.92,  95% CI  0.74  to  11.49,  P = 0.13).  For  the functional  result,  obese  patients  acquired
relatively  lower  Harris  Hip  Score  than  non-obese  patients  (MD:  −2.75, 95%  CI  −4.77 to  −0.6),  no  differ-
ence  was  found  regarding  Oxford  Hip  Score  (MD:  −0.46,  95%  CI −2.18 to 1.26,  P = 0.60).  Obese  patients
compared  to  non-obese  patients  showed  an increase  duration  of operation  (MD:  10.67,  95%  CI 3.00  to
18.35,  P  = 0.006).  However,  no  signiﬁcant  difference  was  found  in  the length  of stay  in  hospital  between
obese  and  non-obese  patients  (MD:  −0.16, 95%  CI −0.34  to 0.02,  P  = 0.08).
Conclusions:  This  meta-analysis  of prospective  cohort  studies  demonstrates  that obesity  negatively  inﬂu-
ences  the overall  complication  rate,  dislocation  rate, functional  outcome  and  operative  time  of  primary
total  hip arthroplasty.
Level of evidence:  Level  II. Low-powered  prospective  randomized  trial.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
More than one million patients undergo total hip arthroplasty
THA) every year, and this number is estimated to double within the
ext two decades [1,2]. It is clear that obesity is a risk for arthritis,
ncreasing need for arthroplasties can be predicted [3]. With the
besity epidemic, the proportion of obese patients needing THA
s on ascension. Studies focusing on the inﬂuence of obesity in
HA also gain its popularity. However, different conclusions were
eported regarding whether obesity has a negative inﬂuence on
rimary THA [4,5]. Some centers have already refused to perform
∗ Corresponding author. Tel.: +86 02 16 43 69 18 1; fax: +86 02 16 47 01 36 1.
E-mail address: zhangxianlong2013s@163.com (X. Zhang).
http://dx.doi.org/10.1016/j.otsr.2015.01.011
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.THA for obese patients considering the high forces acting on the
prosthesis and polyethylene wear unless an acceptable body mass
index (BMI) is obtained [6,7]. Thus, an improved understanding of
the inﬂuence of obesity on THA seems to be necessary. According
to the World Health Organization guideline, BMI  > 30 kg/m2 is con-
sidered obese [8]. We  performed this meta-analysis to compare
outcomes in different groups (BMI < 30, 30–40, > 40 kg/m2) using
the PRISMA protocol. This meta-analysis of 15 prospective studies
was designed to evaluate if obesity negatively affects:• the overall complication rate (incidence of dislocation, deep
infection and osteolysis);
• functional outcome;
• operative time and length of stay in hospital of the primary THA?
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. Methods
.1. Search strategy
Our search strategy was performed in the databases of
ubMed/Medline, Embase, Web  of Science, and the Cochrane
ibrary until July 2014 to identify the eligible prospective cohort
tudies. The search strategy combined free keywords with Mesh
erms as following words:
obesity, obese, body mass index, BMI, overweight, overweighed;
hip arthroplasty, hip replacement, THA;
prospective study(ies), cohort study(ies), longitudinal study(ies).
Only English articles were included. Furthermore, the references
ists of retrieved studies were also checked for additional studies
hat met  the criteria but not found by the electronic search.
.2. Study inclusion and exclusion criteria
Studies that were included in this meta-analysis should meet
he following criteria:
include patients undergoing a primary THA;
include an obese group (BMI > 30 kg/m2) and a non-obese
(BMI < 30 kg/m2) group, the cutoff point of obesity should be
BMI  > 30 kg/m2;
the study design must be a prospective cohort study;
useful outcomes should be reported such as complication rate,
operative time and function score.
Studies were excluded if:
the deﬁnition of obese group was not BMI  > 30 kg/m2;
it was impossible to extract or pool the necessary data from
the published results (not absolutely data but column chart, for
example);
no interested outcome was reported and non-prospective study
design.
Review articles, expert opinions, surgical techniques, and
bstracts from meetings were excluded.
.3. Data Extraction and Quality Assessment
The studies selection and data extraction were independently
ssessed by two reviewers (WL  and TW). Studies were not blinded
egarding author, afﬁliation, or source [9]. Disagreement was
esolved by discussion and eventually determined by a senior
uthor (TC). Outcomes of interest in this study were overall compli-
ation rate, incidence of dislocation, deep infection, and osteolysis,
lood loss, functional score (Harris Hip Score and Oxford Hip Score),
perative time and length of stay in hospital. The data in differ-
nt groups were ﬁnally pooled into three groups (BMI < 30, 30–40,
 40 kg/m2). Besides, the characteristics of each study were also
ecorded as follows: ﬁrst author’s last name, year of publication,
tudy population, country of origin, study period and duration of
ollow-up.
Quality assessment of the prospective cohort studies included
n this meta-analysis was assessed by the Newcastle Ottawa Scale
NOS) as recommended by the Cochrane non-randomized studies
ethods working group, which was composed of three sections
selection, comparability and assessment of outcome) [10]. Con-
ensus was reached on study quality assessment through reviewingurgery & Research 101 (2015) 289–296
the study and discussing the discrepancy. Studies were considered
of high quality if at least 5 of 9 criteria were met.
2.4. Subgroup analysis
It was reported by some studies that patients with
BMI  > 40 kg/m2 suffered a worse outcome of the primary THA
[5,11–13]. We  performed a subgroup analysis for the outcomes
(overall complication rate, incidence of dislocation, deep infection,
Harris Hip Score, operative time, length of stay in hospital) that
contained enough data to be divided into two subgroups (obesity
BMI  30–40 kg/m2 and super-obesity BMI  > 40 kg/m2).
2.5. Statistical analysis
We  used Revman 5.3 software (The Nordic Cochrane Centre,
Copenhagen, Denmark) to pool data, P ≤ 0.05 was thought to be
signiﬁcant. Relative risk (RR) and its 95%CI were used to assess the
association between obesity and its inﬂuence on THA complica-
tion rate, incidence of dislocation, deep infection and osteolysis
across studies. For continuous data, which was  reported with a
range, the SD was  calculated using the method described by Walter
and Yao [14]. Finally, the data was pooled as mean difference (MD)
and its 95%CI. The I2 statistic was used to measure inconsistency
across studies [15]. The data was pooled using ﬁxed-effect (Mantel-
Haenszel test) when no statistical heterogeneity was  detected
between studies (P > 0.10; I2 < 50%). Otherwise, the random-effect
(DerSimonian-Laird method) model was  used. We  also performed
a sensitivity analysis to explore possible explanations for hetero-
geneity.
3. Results
3.1. Study collection
One thousand and seventeen articles were identiﬁed through
databases search, 654 records were left after the removal of dupli-
cates, and ﬁnally, 625 were excluded after the screening of title
and abstract. The remaining 29 articles were carefully viewed full-
text, subsequently, 14 were excluded because of inconsistent with
the inclusion or exclusion criteria. Finally, 15 studies were eligi-
ble for this meta-analysis including 11,271 THA [4,9,11–13,16–25].
Among the whole included studies, only four studies had a cut-
off point of BMI  > 40 kg/m2 [5,11–13]. More details were shown in
Fig. 1.
3.2. Study characteristics
Fifteen prospective studies were included in this meta-analysis,
which were published ranging from 1999 to 2013. Among the
included studies, 5 were performed in UK [5,13,17,20,24], 2 in
Germany [16,22], 2 in USA [11,23], 2 in Switzerland [18,21], 3 in
Australia [4,12], 1 in Swedish [19]. As for the follow-up time, it
ranged from 3 months to 18 years. More detailed information about
the study characteristics was presented in Table 1.
Not all of the studies contain the deﬁned interest of outcomes:
10 studies for complication rate (2 for super-obese group), 6 studies
for dislocation (2 for super-obese group), 3 for deep infection, 3 for
osteolysis, 4 for blood loss, 2 for Oxford Hip Score, 6 for Harris Hip
Score (2 for super-obese group). Regarding operative time, 7 studies
were pooled (2 for super-obese group), 6 studies for length of stay in
hospital (2 for super-obese group). Because the number of included
studies about the complication rate reached 10, we  performed a
funnel plot to assess the publication bias.
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Fig. 1. Flowchart detailing the selection of studies.
Table 1
Characteristics of studies included in the meta-analysis.
Study Setting Enrolment time Group (BMI kg/m2) N Follow-up (year)
Dienstknecht et al., 2013 [16] Germany 2010 < 30, ≥ 30 134 < 1
Raphael et al., 2013 [11] USA 2011 < 25, 25–30, 30–39.9, ≥ 40 50 < 1
Michalka et al., 2012 [4] Australia 2005 to 2007 < 30, 30–35, > 35 191 < 1
Davis  et al., 2011 [17] UK 1998 to 2005 < 25, 25–30, 30–34.9, ≥ 35 1617 5
Lubbeke et al., 2010 [18] Switzerland 1996 to 2003 < 25, 25–29.9, ≥ 30 503 5 to 10
Chee  et al., 2010 [13] UK 1998 to 2003 < 30, 30–39.9, ≥ 40 110 5
Dowsey et al., 2010 [12] Australia 2005 to 2007 < 30, 30–39.9, ≥ 40 471 1
Jackson et al., 2009 [25] Australia 1997 to 2006 < 30, ≥ 30 1659 0 to 11
Andrew  et al., 2008 [5] UK 1999 to 2007 < 30, 30–39.9, ≥ 40 1059 5
Sadr  Azodi et al., 2008 [19] Swedish 1997 to 2004 < 25, 25–29.9, ≥ 30 2085 3
Lubbeke et al., 2007 [21] Switzerland 1996 to 2005 < 30, ≥ 30 2495 5
Kessler et Kafer, 2007 [22] Germany 2005 < 25, 25–29.9, ≥ 30 67 < 1
Patel  and Albrizio, 2007 [20] UK 2002 to 2005 < 25, 25–29, 30–34, > 34 550 1
McLaughlin and Lee, 2006 [23] USA 1983 to 1987 < 25, 25–30, 30–34.9, ≥ 35 198 10 to 18
Bowditch and Villar, 1999 [24] UK Not mentioned < 26, 25–30, > 30 82 < 1
Total  11,271
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.3. Overall complications
Ten articles reported overall complications. To be speciﬁc, the
nterested data of this outcome included major and minor com-
lications (such as deep infection, dislocation, osteolysis, aseptic
oosening et al, minor such as wound healing, hematoma, super-
cial infection et al). A random-effect model was employed in
ooling the data about the overall complications, since high hetero-
eneity was observed among the 10 studies (P = 0.0004, I2 = 69%).
he calculated results demonstrated that obese patients had a sig-
iﬁcant higher complication rate than non-obese patients (RR: 1.68,
5% CI 1.23 to 2.30, P = 0.0004) (Fig. 2). Besides, because of the rel-
tive high heterogeneity, we performed a sensitivity analysis. One
ncluded study [21] was found to strongly increase the heterogene-
ty, and the I2 decreased from 69% to 12% when excluding this study
21], but the overall result didn’t reverse (RR: 1.45, 95% CI 1.20
o 1.76, P < 0.0001). As to the subgroup, 2 studies reported overall
omplications about super-obese patients, the pooled result didn’t
eveal negative inﬂuence of super-obesity on the complications
RR: 2.19, 95% CI 0.71 to 6.72, P = 0.17) (Fig. 2).
.4. Dislocations
Six included studies recorded the dislocation incidences. No
igniﬁcant heterogeneity was found for the overall dislocation anal-
sis (P = 0.99, I2 = 0%). The overall result for dislocation displayed a
igher dislocation rate in obese patients than non-obese patients
RR: 2.08, 95% CI 1.54 to 2.81, P < 0.0001). Contrast to the overall
utcome, the subgroup result of super-obese patients didn’t show
 higher dislocation rate than non-obese patients (RR: 3.27, 95% CI
.67 to 15.91, P = 0.14), which probably resulted from the lack of
ower in the super-obese group (Fig. 3)..5. Deep infection and osteolysis
Meta-analysis for incidence of deep infection and osteolysis
ere performed using random-effect model (P = 0.10, I2 = 52%) ands – Forest plot.
ﬁxed-effected model (P = 0.35, I2 = 4%) respectively. Overall result
demonstrated that obese patient appeared to undergo a higher
deep infection rate than non-obese patients (RR: 2.92, 95% CI 0.74 to
11.49, P = 0.13) (Fig. 4), no signiﬁcant difference was  observed about
the osteolysis (RR: 1.32, 95% CI 0.95 to 1.82, P = 0.09) (Appendix A:
Fig. A). A sensitivity analysis was  done to the incidence of deep
infection. Exclusion of the included study by McLaughlin and Lee
[23], which had a relatively less patients than other studies [5,21]
included in the analysis of deep infection, resolved the heterogene-
ity and reversed the results (I2 = 0%, RR = 5.06, 95% CI 2.46 to 10.43,
P < 0.0001).
3.6. Blood loss
Four studies were included for the analysis of blood loss.
A random-effect model was employed owing to heterogeneity
(P = 0.0003, I2 = 84%). The obese patients bled more during the oper-
ation than non-obese patients (MD: 207.43, 95% CI 6.80 to 408.05,
P = 0.04) (Fig. 5). However, when exclusion of the study by Dien-
stknecht et al. [16], which was  performed through minimal invasive
surgical techniques compared to other included studies, the I2
decreased from 84% to 0%. The MD changed from 207.43 to 315.49
(I2 = 0%, MD:  315.49, 95% CI 242.90 to 388.08).
3.7. Functional score
As to functional score, the data of Oxford Hip Score and Har-
ris Hip Score were pooled. Only 2 studies were included for Oxford
Hip Score, 6 studies for Harris Hip Score. A ﬁxed-effect model was
employed to Oxford Hip Score, the results demonstrated that no
heterogeneity between the groups (P = 0.65, I2 = 0%) and no dif-
ference was observed between the obese and non-obese patients
on Oxford Hip Score (MD: −0.46, 95% CI −2.18 to 1.26, P = 0.60)
(Appendix A: Fig. B). However, the overall data for Harris Hip Score
was pooled using the random-effect model (P = 0.02, I2 = 60%), a
slight lower Harris Hip Score was  observed in the obese patients
than non-obese groups (MD: −2.75, 95% CI −4.77 to −0.6, P = 0.07)
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Fig. 3. Dislocations – Forest plot.
Fig. 4. Deep infection – Forest plot.
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Fig. 6). The heterogeneity couldn’t be changed from high to low
r moderate by exclusion of any single study. A relative lower Har-
is Hip Score was observed in the subgroup of super-obesity (MD:
6.74, 95% CI −10.66 to −2.82, P = 0.0008).
.8. Operative time
Seven articles were eligible for the data extraction of operative
ime. A random-effect model was used to pool the data owing to
he heterogeneity (P < 0.00001, I2 = 87%). The overall pooled results
f the 7 studies showed a signiﬁcant difference between obese
atients and non-obese patients (MD: 10.67, 95% CI 3.00 to 18.35,
 = 0.005) (Appendix A: Fig. C). Obese patients appeared to undergo
 longer duration of operation. Sensitivity analysis revealed that
xclusion of any single study didn’t alter the high heterogeneity. Forest plot.
Regarding the subgroup of super-obesity, the pooled data exhib-
ited a signiﬁcant increase time of the operation for super-obese
patients (MD: 37.59, 95% CI 22.99 to 52.19, P < 0.0001).
3.9. Length of stay in hospital
Regarding the length of stay in hospital, there were 6 studies
employed in the data analysis. The overall heterogeneity was not
signiﬁcant (P = 0.12, I2 = 12%), the pooled result was calculated using
the ﬁxed-effect model. In contrast to results mentioned above, the
length of stay in hospital pooled data showed neither signiﬁcant
difference in the overall result nor the super-obesity group (respec-
tively MD:  −0.16, 95% CI −0.34 to 0.02, P = 0.08, MD:  −0.43, 95% CI
−1.91to 1.05, P = 0.09) (Appendix A: Fig. D).
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Fig. 6. Harris Hip Score – Forest plot.
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Table 2
Newcastle-Ottawa Scale for the included studies.
Study Selection Comparability Exposure
Dienstknecht et al., 2013 [16]
Raphael et al., 2013 [11]
Michalka et al., 2012 [4]
Davis et al., 2011 [17]
Lubbeke et al., 2010 [18]
Chee et al., 2010 [13]
Downsey et al., 2010 [12]
Jackson et al., 2009 [25]
Andrew et al., 2008 [5]
Sadr Azodi et al., 2008 [19]
Lubbeke et al., 2007 [21]
Kessler and Kafer, 2007 [22]
Patel and Albrizio, 2007 [20]Fig. 7. Complications – Funnel plot.
.10. Publication bias
The funnel plot of the overall complication rate was employed
o evaluate publication bias. As the funnel plot showed, a mild
symmetry was exhibited which reﬂected a slight publication bias
Fig. 7). However, only 10 studies were included in the funnel plot,
he result should be interpreted cautiously.
.11. Quality assessment
The Newcastle Ottawa Scale (NOS) was used to assess the
5 eligible prospective studies. All the articles were scored accord-
ng the three sections of NOS (selection, comparability and
ssessment of outcome). Finally, all the 15 studies were of high
uality (meeting 5 or more NOS criteria) (Table 2).
. Discussion
Obesity is on the rise, becoming a worldwide epidemic because
f popularity in unhealthy diet and sedentary lifestyle. It is well
nown that obesity increases the likelihood of various diseases,
articularly heart disease, diabetes, obstructive sleep apnea, cer-
ain types of cancer, and osteoarthritis in low limbs [26,27]. Obesity
lso draws the orthopedic community attention [28,29]. Some
urgeons argued that obese patients seemed to suffer a longerMcLaughlin and Lee, 2006 [23]
Bowditch and Villar, 1999 [24]
duration of operation and worse outcomes [30–32]. A meta-
analysis and system review about the topic was  published in 2011
[33], which included not only prospective studies but also ret-
rospective studies, suggesting that obesity appeared to have a
negative inﬂuence on the outcome of total hip replacement [33].
However, some recent prospective studies reported the contro-
versial results [4,11,16]. Some studies argued that there is no
difference in operative times, lengths of stay and complication rate
between non-obese and obese patients [4,34,35]. A signiﬁcant dif-
ference in the outcomes of THA was  seen in other similar studies
[5,11,35]. Some centers have already refused to perform THA for
obese patients until a targeted body mass index (BMI) is obtained
[6]. In order to clarify the inﬂuence of obesity on THA, we  performed
a meta-analysis of prospective cohort studies but not the retro-
spective studies for its latent bias. We  included some new studies
the former meta-analysis did not contain. We  made cutoff points
2of BMI  < 30, 30–40, > 40 kg/m . Studies which did not set a cutoff
point of BMI  > 30 were excluded in this meta-analysis. Finally, 15
studies were eligible for data analysis.
The current meta-analysis has limitations:
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though 15 prospective studies were included in the data extrac-
tion, not all of the studies allowed retrieval of pooling data for the
deﬁned outcomes. Ten studies were included in the data analysis
of overall complications, which contained most studies among
the interest of outcomes;
the number of THA performed in the included studies varied from
50 to 2495, which may  contribute to the outcomes bias and het-
erogeneity. Besides, the length of follow-up also ranged from
3 months to 18 years;
some confounding factors (such as diabetes, denutrition, osteo-
porosis) that may  affect the outcomes of THA were not adjusted
in the included studies, which may  inﬂuence the ﬁnal results;
we did try to contact the authors for some original data of some
studies, no response was returned. Some data of the deﬁned out-
comes was unable to extract, resulting in missing for the data
analysis.
Among the 15 included studies, only 4 had a cutoff point of
MI  > 40, which resulted in relatively low power of the pooling data
or super-obesity group. Furthermore, all the included studies did
ot contain the whole interested outcomes pooled in our studies. As
o the overall complications, 10 studies were employed in analysis,
 for Harris Hip Score, 7 for operative time, and 6 for length of stay
n hospital. The confounding factors were adjusted in 5 included
tudies [13,16,17,22,25]. Obese patients were more likely to have
omorbidity than non-obese patients, and the comorbidity may
ause higher complication rate. So far, there was  no evidence that
bese patients without comorbidity had a lower risk of complica-
ions than the obese with comorbidity, which was  also similar to
he non-obese. Despite of the limitations, the whole 15 studies were
n line with the inclusion criteria. We  attentively reviewed and
xtracted data from the included studies, the main distinguished
actor BMI  was consistent in the included studies, all the patients
nderwent primary THA, and all the studies included were prospec-
ive. We  demonstrated that the pooled results in our study were
eliable.
The pooled result about the overall complications displayed that
bese patients suffered higher complication rate than non-obese
atients. To be speciﬁc, we also analyzed the incidence of dislo-
ation, deep infection and osteolysis. Higher dislocation rate was
ound in the obese patients, which was in line with former stud-
es [33,36]. The reasons of the higher complication rate in obese
atients may  focus on that patients with high weight owned a
ass of adipose and muscle tissues, which may  make the THA
urgery more difﬁcult and time-consuming, especially in the proce-
ures of exposure and prosthesis insertion [37]. In addition, obese
atients not only undergo more soft damage because of longer
perative time but also have higher force on the prosthesis, which
ay  increase the risk of early loosening, dislocation and prosthesis
ear [36–39]. The difﬁculty of exposure, time-consuming opera-
ion, denutrition and micro-inﬂammation status (which is common
n obese patients) [40–43] may  enhance the possibility of contam-
nation both in superﬁcial and deep position. However, our result
id not display a higher deep infection rate of obese patients, which
ay  account for the powerless and heterogeneity of the included
tudies (Fig. 4).
For the functional score, the data of Oxford Hip Score and
arris Hip Score were extracted and pooled. No statically dif-
erence was observed between the obese and non-obese group
egarding Oxford Hip Score. Contrast to Oxford Hip Score, obese
atients addressed a minimal lower Harris Hip Score than non-
bese patients. Six studies were included for analysis of Harris Hip
core, which was more powerful than Oxford Hip Score (2 studies
ncluded). Thus, we believed that the Harris Hip Score in the present
tudy was more reliable for the functional score evaluation, obese
[
[urgery & Research 101 (2015) 289–296 295
patients had a slightly lower subjective functional score than non-
obese patients.
As for operative time, obese patients had a longer duration
of operation than non-obese patients. The difﬁculty of operation
exposure and prosthesis insertion may  account for a longer dura-
tion of surgery in obese patients. On the contrary to operative time,
there was no signiﬁcant difference between obese and non-obese
patients on length of stay in hospital. It was not surprising that
the length of stay in hospital did not differ between the obese
group and non-obese group, because patients in medical centers
were usually admitted in the standard clinical pathway, all patients
who underwent THA would go through the standard procedures
from admission to discharge. Unless some major complications
happened during hospitalization, the long of stay in hospital was
similar between the obese and non-obese patients.
5. Conclusions
To our knowledge, this is the ﬁrst meta-analysis and system-
atic review of prospective studies on the inﬂuence of obesity on
primary THA. Fifteen prospective studies were included for this
meta-analysis. The results suggest that obesity has a negative inﬂu-
ence on the complication rate (incidence of dislocation), functional
outcome and operative time of primary total hip arthroplasty.
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